Cargando…

Locoregional therapies for the treatment of locally advanced hepatocellular carcinoma

Detalles Bibliográficos
Autor principal:	da Motta-Leal-Filho, Joaquim Maurício
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Publicação do Colégio Brasileiro de Radiologia e Diagnóstico por Imagem 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177675/ https://www.ncbi.nlm.nih.gov/pubmed/34108772 http://dx.doi.org/10.1590/0100-3984.2021.54.3e3

Ejemplares similares

Combined locoregional and systemic therapy for advanced hepatocellular carcinoma: finally, the future is obscure
por: Farsad, Khashayar, et al.
Publicado: (2020)

Recent Advances in Locoregional Therapy of Hepatocellular Carcinoma
por: Podlasek, Anna, et al.
Publicado: (2023)

Advances in locoregional therapy for hepatocellular carcinoma combined with immunotherapy and targeted therapy
por: Xue, Jian, et al.
Publicado: (2021)

All Stages of Hepatocellular Carcinoma Patients Benefit from Systemic Therapy Combined with Locoregional Therapy
por: Kudo, Masatoshi
Publicado: (2023)

Induction gemcitabine and cisplatin in locoregionally advanced nasopharyngeal carcinoma
por: Zhang, Yuan, et al.
Publicado: (2019)

Locoregional Therapy Approaches for Hepatocellular Carcinoma: Recent Advances and Management Strategies
por: Makary, Mina S., et al.
Publicado: (2020)

Salvage locoregional therapies for recurrent hepatocellular carcinoma
por: Criss, Cody R, et al.
Publicado: (2023)

Hepatocellular carcinoma locoregional therapies: Outcomes and future horizons
por: Makary, Mina S, et al.
Publicado: (2021)

MRI assessment of hepatocellular carcinoma after locoregional therapy
por: Hussein, Rasha S., et al.
Publicado: (2019)

Locoregional Combined With Systemic Therapies for Advanced Hepatocellular Carcinoma: An Inevitable Trend of Rapid Development
por: Li, Xin, et al.
Publicado: (2021)

Locoregional Therapies for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
por: Zane, Kylie E., et al.
Publicado: (2021)

Combination Therapy of Immune Checkpoint Inhibitors with Locoregional Therapy for Hepatocellular Carcinoma
por: Tamai, Yasuyuki, et al.
Publicado: (2023)

Orthotopic liver transplantation after the combined use of locoregional therapy and sorafenib for advanced hepatocellular carcinoma
por: Yoo, Eun Jin, et al.
Publicado: (2013)

Drug-Off Criteria in Patients with Hepatocellular Carcinoma Who Achieved Clinical Complete Response after Combination Immunotherapy Combined with Locoregional Therapy
por: Kudo, Masatoshi
Publicado: (2023)

Locoregional treatments for hepatocellular carcinoma: Current evidence and future directions
por: Inchingolo, Riccardo, et al.
Publicado: (2019)

Locoregional therapy response in patients with hepatocellular cancer waiting for liver transplantation: Only selection or biological effect?
por: Lai, Quirino, et al.
Publicado: (2018)

The Synergistic Effect of Interventional Locoregional Treatments and Immunotherapy for the Treatment of Hepatocellular Carcinoma
por: Brandi, Nicolò, et al.
Publicado: (2023)

Recent Advancements for the Treatment of Hepatocellular Carcinoma
por: Nouso, Kazuhiro
Publicado: (2023)

Development of conversion therapy for advanced hepatocellular carcinoma
por: Matsuki, Ryota, et al.
Publicado: (2023)

Post Locoregional Therapy Treatment Imaging in Hepatocellular Carcinoma Patients: A Literature-based Review
por: Young, Shamar, et al.
Publicado: (2018)

Anti-Glycolytic Drugs in the Treatment of Hepatocellular Carcinoma: Systemic and Locoregional Options
por: Pourbaghi, Miles, et al.
Publicado: (2023)

Non-Surgical Locoregional Therapies Alone or in Combination with Systemic Therapy in Patients with Hepatocellular Carcinoma
por: Chami, Perla, et al.
Publicado: (2023)

Treatment intensity in locoregionally advanced head and neck cancer: recent investigation leads to new questions
por: Bonner, James A., et al.
Publicado: (2019)

Locoregional therapy patterns and healthcare economic burden of patients with hepatocellular carcinoma in the USA
por: Aly, Abdalla, et al.
Publicado: (2021)

Locoregional therapy in hepatocellular carcinoma: when to start and when to stop and when to revisit
por: Lee, J.J.X., et al.
Publicado: (2021)

Pretransplant Locoregional Therapy for Hepatocellular Carcinoma: Evaluation of Explant Pathology and Overall Survival
por: Beal, Eliza W., et al.
Publicado: (2016)

Friend or Foe? Locoregional Therapies and Immunotherapies in the Current Hepatocellular Treatment Landscape
por: Young, Shamar, et al.
Publicado: (2023)

Locoregional Treatments in Cholangiocarcinoma and Combined Hepatocellular Cholangiocarcinoma
por: Renzulli, Matteo, et al.
Publicado: (2021)

Combination approaches in hepatocellular carcinoma: How systemic treatment can benefit candidates to locoregional modalities
por: da Fonseca, Leonardo Gomes, et al.
Publicado: (2022)

Evolution of systemic therapy for advanced-stage hepatocellular carcinoma
por: Hur, Moon Haeng, et al.
Publicado: (2022)

Systematic review of treatment strategy for recurrent hepatocellular carcinoma: Salvage liver transplantation or curative locoregional therapy
por: Wang, Hong-Liang, et al.
Publicado: (2019)

Induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma
por: Li, Wen-Fei, et al.
Publicado: (2016)

Prognostic Nomogram For Locoregionally Advanced Nasopharyngeal Carcinoma
por: Jiang, Yanming, et al.
Publicado: (2020)

Molecular Imaging of Tumor Microenvironment to Assess the Effects of Locoregional Treatment for Hepatocellular Carcinoma
por: Chen, Quan, et al.
Publicado: (2021)

CT Appearance of Hepatocellular Carcinoma after Locoregional Treatments: A Comprehensive Review
por: Marin, Daniel, et al.
Publicado: (2015)

Favourable outcome of pathologic downstaging by locoregional treatment for hepatocellular carcinoma in liver transplantation
por: Kim, Deok Gie, et al.
Publicado: (2019)

Update on Locoregional Therapies for Cholangiocellular Carcinoma
por: Morawitz, Janna, et al.
Publicado: (2023)

Sorafenib and locoregional deep electro-hyperthermia in advanced hepatocellular carcinoma: A phase II study
por: GADALETA-CALDAROLA, GENNARO, et al.
Publicado: (2014)

Feasibility study of personalized peptide vaccination for hepatocellular carcinoma patients refractory to locoregional therapies
por: Yutani, Shigeru, et al.
Publicado: (2017)

Histology of Hepatocellular Carcinoma: Association with Clinical Features, Radiological Findings, and Locoregional Therapy Outcomes
por: Park, Benjamin V., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jruesc35j3844rapv7c5592e5j